← Leaderboards
Yuanpu Peter Di
University Of Pittsburgh At Pittsburgh
$9,824,961
Attributed
$13,597,533
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.1M · FY2008–25$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,597,533 · 8
By mechanism
R01$12,503,947 · 5
R56$616,411 · 1
K22$292,800 · 1
R21$184,375 · 1
Top collaborators
- Hong W Chu5 shared
- Jian Li2 shared
- Yin Chen1 shared
- George Douglas Leikauf1 shared
- Heidi M. Mansour1 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Berthony Deslouches$3,985,460
Others in their field
Top investigators on “Lung”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$372,040,227
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$201,818,043
- Walter John Curran · Thomas Jefferson University$112,093,071
Research focus
LungBacteriaEpithelial CellsInfectionMediatingPredispositionIn VivoPathogenProteinsAntimicrobialAirway EpitheliumUnited StatesHost DefenseRespiratory Tract InfectionsIncidenceAntibiotic ResistanceProgramsPeptidesLiquid SubstanceIn VitroAntimicrobial DrugCellsPseudomonas AeruginosaBacterial Infections
Grant awards (28)
Airway Innate Immune Responses to Coccidioides Infection$3,075,549
R01 · FY2025 · AI
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms$840,040
R01 · FY2025 · AI · contact PI
Optimization of a novel antimicrobial for pulmonary delivery to fight respiratory infections$184,375
R21 · FY2025 · AI · contact PI
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms$867,033
R01 · FY2024 · AI · contact PI
Developing a novel class of peptide antibiotics targeting carbapenem-resistant Gram-negative organisms$880,743
R01 · FY2023 · AI · contact PI
Cellular and molecular mechanisms of e-cigarette vaping-induced acute lung injury$616,411
R56 · FY2022 · HL · contact PI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection$524,705
R01 · FY2021 · AI · contact PI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection$525,483
R01 · FY2020 · AI · contact PI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection$526,238
R01 · FY2019 · AI · contact PI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection$526,238
R01 · FY2018 · AI · contact PI
SPLUNC1 in Severe Asthma$490,516
R01 · FY2018 · HL · contact PI
Novel antimicrobial agents to overcome antibiotic resistant Pseudomonas and MRSA respiratory infection$538,447
R01 · FY2017 · AI · contact PI
SPLUNC1 in Severe Asthma$490,516
R01 · FY2017 · HL · contact PI
SPLUNC1 in Severe Asthma$490,516
R01 · FY2016 · HL · contact PI
SPLUNC1 in Severe Asthma$44,401
R01 · FY2016 · HL · contact PI
SPLUNC1 in Severe Asthma$405,084
R01 · FY2015 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$392,962
R01 · FY2012 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$398,446
R01 · FY2011 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$58,412
R01 · FY2011 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$3,457
R01 · FY2011 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$373,600
R01 · FY2010 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$57,990
R01 · FY2010 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$373,600
R01 · FY2009 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$246,371
R01 · FY2009 · HL · contact PI
Epithelial PLUNC as a determinant of Airway Mucosal Antimicrobial Activity$373,600
R01 · FY2008 · HL · contact PI
Effects of Tobacco Smoke on Airway Bactericidal Activity$108,000
K22 · FY2004 · ES
Effects of Tobacco Smoke on Airway Bactericidal Activity$108,000
K22 · FY2003 · ES
Effects of Tobacco Smoke on Airway Bactericidal Activity$76,800
K22 · FY2002 · ES